Literature DB >> 16131891

Excision of heterotopic ossification from the knee: a functional outcome study.

David A Fuller1, Arthur Mark, Mary Ann E Keenan.   

Abstract

UNLABELLED: We retrospectively reviewed 17 consecutive patients with neurologic injuries (22 knees) who had excision of heterotopic ossification (22 knees, five bilateral) of the knees. Our primary research goal was to determine the change in range of motion at the knee after resection of heterotopic ossification in patients with neurologic injuries. Our secondary research goal was to determine the mobility gains measured regarding ambulatory and sitting functions for these patients. Diagnoses included traumatic brain injury (15 patients), anoxia (one patient), and spinal cord injury (one patient). The average age of the patients was 33 years (range, 19-51 years). Data were collected by an independent observer and included range of motion of the knee, ambulatory ability according to a five-level scale, and sitting ability according to a three-level scale. The average followup was 32 months. Range of motion improved by 65 degrees postoperatively. Extension improved from a preoperative mean of 16 degrees to a postoperative mean of 2 degrees . Flexion improved from a preoperative mean of 57 degrees to a postoperative mean of 107 degrees . Ambulatory and sitting function improved as a result of treatment. Surgical excision of heterotopic ossification of the knee is an effective procedure to increase joint mobility and function. LEVEL OF EVIDENCE: Therapeutic study, Level IV (case series-no, or historical control group). See the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2005        PMID: 16131891     DOI: 10.1097/00003086-200509000-00033

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  8 in total

1.  Functional outcome after excision of heterotopic ossification about the knee in ICU patients.

Authors:  G I Mitsionis; M G Lykissas; N Kalos; N Paschos; A E Beris; A D Georgoulis; T A Xenakis
Journal:  Int Orthop       Date:  2008-07-19       Impact factor: 3.075

Review 2.  A comparison of heterotopic ossification treatment within the traumatic brain and spinal cord injured population: An evidence based systematic review.

Authors:  Jo-Anne L Aubut; Swati Mehta; Nora Cullen; Robert W Teasell
Journal:  NeuroRehabilitation       Date:  2011       Impact factor: 2.138

Review 3.  Beliefs relating to recurrence of heterotopic ossification following excision in patients with spinal cord injury: a review.

Authors:  F Genêt; A Ruet; W Almangour; L Gatin; P Denormandie; A Schnitzler
Journal:  Spinal Cord       Date:  2015-02-17       Impact factor: 2.772

4.  Acceptable outcome following resection of bilateral large popliteal space heterotopic ossification masses in a spinal cord injured patient: a case report.

Authors:  Ramin Espandar; Babak Haghpanah
Journal:  J Orthop Surg Res       Date:  2010-06-22       Impact factor: 2.359

5.  Troublesome heterotopic ossification after central nervous system damage: a survey of 570 surgeries.

Authors:  François Genêt; Claire Jourdan; Alexis Schnitzler; Christine Lautridou; Didier Guillemot; Thierry Judet; Serge Poiraudeau; Philippe Denormandie
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

6.  The impact of preoperative hip heterotopic ossification extent on recurrence in patients with head and spinal cord injury: a case control study.

Authors:  François Genêt; Claire Jourdan; Christine Lautridou; Clément Chehensse; Kambiz Minooee; Philippe Denormandie; Alexis Schnitzler
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

7.  Extensive heterotopic ossification in patient with tubercular meningitis.

Authors:  Vijai Prakash Sharma; Ganesh Yadav; Anil Kumar Gupta; Dileep Kumar
Journal:  J Neurosci Rural Pract       Date:  2014-11

Review 8.  Treatments and Preventative Measures for Trauma-Induced Heterotopic Ossification: A Review.

Authors:  Jessica K Juarez; Joseph C Wenke; Jessica C Rivera
Journal:  Clin Transl Sci       Date:  2018-04-26       Impact factor: 4.689

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.